Evidence map›Paper›PMID 34698450›Full record

ArticleJournal of cellular and molecular medicine2021

HIF-1α promotes the proliferation and migration of pulmonary arterial smooth muscle cells via activation of Cx43.

Xiao-Jian Han, Wei-Fang Zhang, Qin Wang, Min Li, Chun-Bo Zhang, Zhang-Jian Yang, Ren-Jie Tan, Li-Jun Gan, Le-Ling Zhang, Xue-Mei Lan and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Role of histone lactylation interference RNA mFrontiers in cell and developmental biology · 2023
    Review
  10. Review
  11. Connexins and Glucose Metabolism in Cancer.International journal of molecular sciences · 2022
    Review
  12. Stem cell therapy for pulmonary arterial hypertension: An update.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Review
  13. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Xiao-Jian HanKey Laboratory of Drug Targets and Drug Screening of Jiangxi Province, Nanchang, China.
Wei-Fang ZhangDepartment of Pharmacy, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Qin WangDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Min LiDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Chun-Bo ZhangKey Laboratory of Drug Targets and Drug Screening of Jiangxi Province, Nanchang, China.
Zhang-Jian YangDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Ren-Jie TanDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Li-Jun GanDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Le-Ling ZhangDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Xue-Mei LanDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Fang-Lin ZhangDepartment of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Tao HongDepartment of Neurosurgery, First Affiliated Hospital of Nanchang University, Nanchang, China.
Li-Ping JiangKey Laboratory of Drug Targets and Drug Screening of Jiangxi Province, Nanchang, China.ORCID 0000-0002-1429-4164
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proliferation of pulmonary artery smooth muscle cells (PASMCs) is an important cause of pulmonary vascular remodelling in hypoxia-induced pulmonary hypertension (HPH). However, its underlying mechanism has not been well elucidated. Connexin 43 (Cx43) plays crucial roles in vascular smooth muscle cell proliferation in various cardiovascular diseases. Here, the male Sprague-Dawley (SD) rats were exposed to hypoxia (10% O

Indexed as

AnimalsCell ProliferationCells, CulturedConnexin 43HypoxiaHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryModels, BiologicalMuscle, Smooth, VascularMyocytes, Smooth MusclePhosphorylationPromoter Regions, GeneticProtein BindingPulmonary ArteryRatsConnexin 43Hif1a protein, ratHypoxia-Inducible Factor 1, alpha Subunitconnexin 43hypoxiahypoxia-induced pulmonary hypertensionmigrationproliferationpulmonary artery smooth muscle cells

Identifiers

PMID34698450
PMCPMC8581339
OpenAlexW3209746938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.